Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2010 2
2012 1
2013 1
2014 3
2015 2
2016 3
2017 2
2018 1
2019 3
2020 4
2021 2
2022 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbøll T, Warren ML, Bain SC; PIONEER 6 Investigators. Husain M, et al. N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11. N Engl J Med. 2019. PMID: 31185157 Clinical Trial.
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
Seroprevalence of anti-SARS-CoV-2 antibodies in Indore, Madhya Pradesh: A community-based cross-sectional study, August 2020.
Sakalle S, Saroshe S, Shukla H, Mutha A, Vaze A, Arora A, Athotra A, Ramaswamy S, Jain A, Dhuria M, Patil AD, Rai A, Garg S, Jain SK, Bindal J, Singh SK. Sakalle S, et al. Among authors: mutha a. J Family Med Prim Care. 2021 Mar;10(3):1479-1484. doi: 10.4103/jfmpc.jfmpc_2015_20. Epub 2021 Apr 8. J Family Med Prim Care. 2021. PMID: 34041197 Free PMC article.
Evaluation of the Safety and Efficacy of Favipiravir in Adult Indian Patients with Mild-to-Moderate COVID-19 in a Real-World Setting.
Reddy PK, Patil S, Khobragade A, Balki A, Raj A, Kalikar M, Reddy R, Shinde R, Cr J, Mutha A, Boyilla N, Rajadhyaksha GC, Karnik N, Bhagat S, Pendse A, Dhage P, Wu W, Rangwala S, Barkate H. Reddy PK, et al. Among authors: mutha a. Int J Gen Med. 2022 May 3;15:4551-4563. doi: 10.2147/IJGM.S349241. eCollection 2022. Int J Gen Med. 2022. PMID: 35535140 Free PMC article. Clinical Trial.
25 results